Lexeo Therapeutics, Inc. Common Stock Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Goods Sold | 546K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | -546K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D Expenses | 15.7M | 16.2M | 15.7M | 14.7M | 17.2M | 18.4M | 23.4M | 16.6M |
| Operating Expenses | 21.8M | 23.1M | 21.6M | 30.7M | 33.8M | 27.4M | 31.5M | 23.6M |
| Operating Income | -22.3M | -23.1M | -21.6M | -30.7M | -33.8M | -27.4M | -31.5M | -23.6M |
| Other Income / Gains | 2.1M | 2.2M | 1.4M | 4.6M | 1.1M | 1.5M | 2.1M | 2.3M |
| Net Income | -20.2M | -20.9M | -20.3M | -26.1M | -32.7M | -25.9M | -29.5M | -21.2M |
| EPS (Diluted) | -0.25 | -0.27 | -0.33 | -0.60 | -0.99 | -0.78 | -0.89 | -0.64 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General And Administrative Expenses | 6.6M | 6.9M | 6.0M | 16.0M | 16.6M | 9.0M | 8.1M | 7.0M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 6.6M | 6.9M | 6.0M | 16.0M | 16.6M | 9.0M | 8.1M | 7.0M |
| Other Expenses | -546K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost And Expenses | 22.3M | 23.1M | 21.6M | 30.7M | 33.8M | 27.4M | 31.5M | 23.6M |
| Interest Income | 2.2M | 2.2M | 1.5M | 1.3M | 1.2M | 1.5M | 2.1M | 2.3M |
| Interest Expense | 17K | 25K | 82K | 59K | 40K | 30K | 35K | 35K |
| Depreciation And Amortization | 546K | 538K | 530K | 510K | 501K | 521K | 509K | 496K |
| Ebitda | -19.6M | -20.4M | -19.7M | -25.5M | -32.1M | -25.4M | -28.9M | -20.7M |
| Ebitdaratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | -20.2M | -20.9M | -20.3M | -26.1M | -32.7M | -25.9M | -29.5M | -21.2M |
| Income Before Tax Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Epsdiluted | -0.25 | -0.27 | -0.33 | -0.60 | -0.99 | -0.78 | -0.89 | -0.64 |
| Weighted Average Shs Out | 81.2M | 76.4M | 61.0M | 43.6M | 33.1M | 33.1M | 33.1M | 33.0M |
| Weighted Average Shs Out Dil | 81.2M | 76.4M | 61.0M | 43.6M | 33.1M | 33.1M | 33.1M | 33.0M |